Andrew Bell

Dr.

Accepting PhD Students

PhD projects

Andrew Bell is a member of a research team interested in the biology of EBV and its role in lymphomagenesis. His work addresses the following areas:

EBV persistence in normal healthy individuals
The effects of EBV infection on cellular phenotype
Virus gene expression in different cell types
The role of EBV in lymphomagenesis

Dr Bell supervises a number of PhD researchers studying the biology of Epstein Barr virus (EBV) and the pathogenesis of EBV-associated lymphomas

1989 …2020

Research activity per year

Network

Steve Busby

Person: Academic

Paul Moss

Person: Academic

Jeff Cole

Person: Honorary

Gary Reynolds

Person: Academic, Honorary

Steve Minchin

Person: Academic

John O'Neil

Person: Academic

Ben Abbotts

Person: Academic-related

Julia Lodge

Person: Academic

Andreas Strasser

  • Walter & Eliza Hall Inst Med Res

External person

gemma Kelly

  • Walter & Eliza Hall Inst Med Res

External person

G Davies

  • Great Ormond Street Hospital NHS Foundation Trust

External person

Kevin Brulios

  • University of Southern California

External person

Andrea Stacey

  • Nuffield Department of Clinical Medicine

External person

Y Peng

  • Sichuan University

External person

Qian Tao

  • The Chinese University of Hong Kong

External person

G Dewson

  • Walter & Eliza Hall Inst Med Res

External person

Nigel H Russell

  • Nottingham University Hospitals NHS Trust

External person

Menno C. Van Zelm

  • Erasmus Medical Center

External person

C D Suraweera

  • La Trobe University

External person

Frederic Sierro

  • Centenary Institute of Cancer Medicine and Cell Biology
  • Garvan Institute of Medical Research

External person

Olga Kondrashova

  • The Walter and Eliza Hall Institute of Medical Research

External person

Jae Jung

  • University of Southern California

External person

Farooq A Wandroo

  • Sandwell and West Birmingham Hospitals NHS Trust

External person

D C S Huang

  • The Walter and Eliza Hall Institute, Parkville, Victoria 3052, Australia;

External person

Marco Herold

  • The Walter and Eliza Hall Institute, Parkville, Victoria 3052, Australia;

External person

S O'Connor

  • United Bristol Healthcare Trust, Directorate of Mental Health, Barrow Hospital, Bristol BS19 3SG.

External person

Y Zhou

  • College of William and Mary

External person

mark Kvansakul

  • La Trobe University

External person

Jacques J M Van Dongen

  • Erasmus Medical Center

External person

Ruth N. MacKinnon

  • Victorian Cancer Cytogenetics Service, St Vincent's Hospital Melbourne, Fitzroy, Victoria 3065, Australia

External person

c chang

  • The Walter and Eliza Hall Institute of Medical Research

External person

Arne N Akbar

  • St Mark’s Hospital
  • Imperial College London
  • University College London Hospitals NHS Foundation Trust

External person

S Moore

  • Open University

External person

P M Colman

  • The Walter and Eliza Hall Institute, Parkville, Victoria 3052, Australia;

External person

Guillaume Lessene

  • The Walter and Eliza Hall Institute of Medical Research

External person

Husam Osman

  • Birmingham Heartlands Hospital

External person

Eva M Campion

  • Dublin City University

External person

D West

  • University of Southampton

External person

Thushan I. De Silva

  • University of Sheffield

External person

L C A Galbraith

  • University of Glasgow

External person

Shereen Sabbah

  • King’s College London

External person